In addition, only CD3-CD56dim cells but not CD3-CD56bright cells from ccRCC patients displayed a significant increased frequency of CD69+ cells (Figures 1H, I), and both subsets from ccRCC patients expressed significantly higher amounts of CD69 (Figures 1J, K). This evidence concerns the gene CD69 and nonpapillary renal cell carcinoma.